abstract |
The invention discloses immunogenic composition containing serological type 19A and 19F S.pneumoiae capsule sugar conjugate, wherein 19A is conjugated with a first type of bacterial toxoid, 19F with a second type of bacterial toxoid. The invention further describes method to prepare the vaccine and usage thereof. |